Johnson & Johnson To Present Data Across Its Neuropsychiatry Portfolio at 2026 Psych Congress Annual Meeting

By Benzinga Newsdesk

Johnson & Johnson (NYSE:JNJ) today announced that 24 abstracts featuring clinical data and real-world evidence across the neuropsychiatry portfolio will be presented at the 2026 Psych Congress Annual Meeting (September 15-19, New Orleans, LA).

Share this article

Keep reading.

TUTORIALS

Johnson & Johnson To Present Data Across Its Neuropsychiatry Portfolio at 2026 Psych Congress Annual Meeting

TUTORIALS

Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

TUTORIALS

Needham Reiterates Hold on Appleto Hold

Trade what
you just read.

Apply the analysis on a live or demo account, same execution, no risk on demo.

Your seat at the market is ready.

Open your account in minutes, transparent pricing, fast withdrawals and support that answers.

Try a free demo

Johnson & Johnson To Present Data Across Its Neuropsychiatry Portfolio at 2026 Psych Congress Annual Meeting

Trade whatyou just read.

Your seat at the market is ready.

Trade what
you just read.